Trial Outcomes & Findings for Facilitating Aftercare for Alcohol Detox Patients (NCT NCT00513708)

NCT ID: NCT00513708

Last Updated: 2020-10-14

Results Overview

Linkage to alcohol behavioral therapy counseling (i.e., "aftercare") was defined as: arriving for the first outpatient chemical dependency counseling visit, being admitted to an inpatient or residential chemical dependency treatment facility, or attending at least one meeting of a help-help program such as Alcoholics Anonymous.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

150 participants

Primary outcome timeframe

1 month

Results posted on

2020-10-14

Participant Flow

Participant milestones

Participant milestones
Measure
Treatment as Usual
Treatment as Usual (TAU): Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during medically managed inpatient detoxification.
Motivational Enhancement Therapy
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Motivational Enhancement Therapy (MET) session delivered by a trained professional.
Peer-delivered Twelve Step Facilitation
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Peer-delivered Twelve Step Facilitation (P-TSF)session delivered by individuals from a common self-help program.
Overall Study
STARTED
50
50
50
Overall Study
COMPLETED
46
46
46
Overall Study
NOT COMPLETED
4
4
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Treatment as Usual
Treatment as Usual (TAU): Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during medically managed inpatient detoxification.
Motivational Enhancement Therapy
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Motivational Enhancement Therapy (MET) session delivered by a trained professional.
Peer-delivered Twelve Step Facilitation
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Peer-delivered Twelve Step Facilitation (P-TSF)session delivered by individuals from a common self-help program.
Overall Study
Lost to Follow-up
4
4
4

Baseline Characteristics

Facilitating Aftercare for Alcohol Detox Patients

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Treatment as Usual
n=50 Participants
Treatment as Usual (TAU): Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during medically managed inpatient detoxification.
Motivational Enhancement Therapy
n=50 Participants
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Motivational Enhancement Therapy (MET) session delivered by a trained professional.
Peer-delivered Twelve Step Facilitation
n=50 Participants
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Peer-delivered Twelve Step Facilitation (P-TSF)session delivered by individuals from a common self-help program.
Total
n=150 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
0 Participants
n=7 Participants
Age, Categorical
Between 18 and 65 years
49 Participants
n=99 Participants
48 Participants
n=107 Participants
49 Participants
n=206 Participants
146 Participants
n=7 Participants
Age, Categorical
>=65 years
1 Participants
n=99 Participants
2 Participants
n=107 Participants
1 Participants
n=206 Participants
4 Participants
n=7 Participants
Age, Continuous
46.58 years
STANDARD_DEVIATION 9.92 • n=99 Participants
44.96 years
STANDARD_DEVIATION 10.75 • n=107 Participants
44.48 years
STANDARD_DEVIATION 12.36 • n=206 Participants
45.34 years
STANDARD_DEVIATION 11.02 • n=7 Participants
Sex: Female, Male
Female
20 Participants
n=99 Participants
25 Participants
n=107 Participants
33 Participants
n=206 Participants
78 Participants
n=7 Participants
Sex: Female, Male
Male
30 Participants
n=99 Participants
25 Participants
n=107 Participants
17 Participants
n=206 Participants
72 Participants
n=7 Participants
Region of Enrollment
United States
50 participants
n=99 Participants
50 participants
n=107 Participants
50 participants
n=206 Participants
150 participants
n=7 Participants

PRIMARY outcome

Timeframe: 1 month

Population: There were 50 participants in each arm. Per protocol, the "number of participants analyzed" represents the number that had outcome data (i.e, "linked to aftercare" or "not linked to aftercare") available at the 30-day follow-up.

Linkage to alcohol behavioral therapy counseling (i.e., "aftercare") was defined as: arriving for the first outpatient chemical dependency counseling visit, being admitted to an inpatient or residential chemical dependency treatment facility, or attending at least one meeting of a help-help program such as Alcoholics Anonymous.

Outcome measures

Outcome measures
Measure
Treatment as Usual
n=44 Participants
Treatment as Usual (TAU): Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during medically managed inpatient detoxification.
Motivational Enhancement Therapy
n=44 Participants
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Motivational Enhancement Therapy (MET) session delivered by a trained professional.
Peer-delivered Twelve Step Facilitation
n=43 Participants
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Peer-delivered Twelve Step Facilitation (P-TSF)session delivered by individuals from a common self-help program.
Linkage to Alcohol Behavioral Therapy Counseling (i.e., "Aftercare")
36 participants
36 participants
32 participants

SECONDARY outcome

Timeframe: 30 days

Population: There were 50 participants in each arm. Per protocol, the "number of participants analyzed" represents the number that had outcome data (i.e, "relapse" or "no relapse") available at the 30-day follow-up.

Relapse to drinking was defined as the consumption of one or more standard drinks (approximately 12 grams of ethanol)during the first 30 days following discharge from the inpatient detoxification unit. The date of discharge was considered to be "Day 1."

Outcome measures

Outcome measures
Measure
Treatment as Usual
n=42 Participants
Treatment as Usual (TAU): Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during medically managed inpatient detoxification.
Motivational Enhancement Therapy
n=43 Participants
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Motivational Enhancement Therapy (MET) session delivered by a trained professional.
Peer-delivered Twelve Step Facilitation
n=41 Participants
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Peer-delivered Twelve Step Facilitation (P-TSF)session delivered by individuals from a common self-help program.
Relapse to Drinking
23 participants
25 participants
20 participants

SECONDARY outcome

Timeframe: 90 days

Population: There were 50 participants in each arm; the "number of participants analyzed" represents the number of those 50 in each arm who were admitted to an inpatient treatment program (e.g., a "28-day program").

Completion of inpatient treatment was defined as being admitted to and successfully discharged from an inpatient alcohol treatment program (e.g., a "28-day program"). Participants who left the inpatient program "against medical advice" or who received an "administrative discharge" were not considered to have successfully completed the inpatient program.

Outcome measures

Outcome measures
Measure
Treatment as Usual
n=19 Participants
Treatment as Usual (TAU): Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during medically managed inpatient detoxification.
Motivational Enhancement Therapy
n=25 Participants
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Motivational Enhancement Therapy (MET) session delivered by a trained professional.
Peer-delivered Twelve Step Facilitation
n=12 Participants
Participants randomized to this arm will receive "usual care" (i.e., pharmacotherapy to manage alcohol withdrawal, counseling and referral to treatment or self-help) during inpatient detoxification plus a 60-minute Peer-delivered Twelve Step Facilitation (P-TSF)session delivered by individuals from a common self-help program.
Completed Inpatient Treatment
15 Participants
21 Participants
9 Participants

Adverse Events

Treatment as Usual

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Motivational Enhancement Therapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Peer-delivered Twelve Step Facilitation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Schieder, Jeffrey

SUNY Buffalo

Phone: 716-645-2977

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place